Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NEULAND LABS   TEVA PHARMA
EQUITY SHARE DATA
    NEULAND LABS
Mar-23
TEVA PHARMA
Dec-13
NEULAND LABS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,0043,461-   
Low Rs9663,006-   
Sales per share (Unadj.) Rs928.41,986.1-  
Earnings per share (Unadj.) Rs127.4124.1-  
Cash flow per share (Unadj.) Rs168.6284.6-  
Dividends per share (Unadj.) Rs10.00108.61-  
Avg Dividend yield %0.73.4 20.0%  
Book value per share (Unadj.) Rs774.82,206.2-  
Shares outstanding (eoy) m12.83848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.61.6 98.2%   
Avg P/E ratio x11.726.1 44.7%  
P/CF ratio (eoy) x8.811.4 77.5%  
Price / Book Value ratio x1.91.5 130.8%  
Dividend payout %7.887.5 9.0%   
Avg Mkt Cap Rs m19,0522,742,000 0.7%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2,0180-   
Avg. sales/employee Rs Th037,473.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,340.9-  
INCOME DATA
Net Sales Rs m11,9121,684,234 0.7%  
Other income Rs m970-   
Total revenues Rs m12,0091,684,234 0.7%   
Gross profit Rs m2,718461,228 0.6%  
Depreciation Rs m528136,138 0.4%   
Interest Rs m13133,081 0.4%   
Profit before tax Rs m2,157292,009 0.7%   
Minority Interest Rs m01,327 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-191,688 -0.0%   
Tax Rs m522-3,565 -14.6%   
Profit after tax Rs m1,635105,213 1.6%  
Gross profit margin %22.827.4 83.3%  
Effective tax rate %24.2-1.2 -1,982.8%   
Net profit margin %13.76.2 219.7%  
BALANCE SHEET DATA
Current assets Rs m7,6091,137,525 0.7%   
Current liabilities Rs m4,390992,018 0.4%   
Net working cap to sales %27.08.6 312.8%  
Current ratio x1.71.1 151.2%  
Inventory Days Days691 7.0%  
Debtors Days Days1,10996 1,155.7%  
Net fixed assets Rs m8,189550,108 1.5%   
Share capital Rs m1294,146 3.1%   
"Free" reserves Rs m9,8120-   
Net worth Rs m9,9411,870,864 0.5%   
Long term debt Rs m742861,186 0.1%   
Total assets Rs m15,7983,849,014 0.4%  
Interest coverage x17.59.8 178.2%   
Debt to equity ratio x0.10.5 16.2%  
Sales to assets ratio x0.80.4 172.3%   
Return on assets %11.23.6 311.1%  
Return on equity %16.45.6 292.5%  
Return on capital %21.44.9 434.3%  
Exports to sales %73.50-   
Imports to sales %15.10-   
Net fx Rs m6,9460-   
CASH FLOW
From Operations Rs m2,372268,380 0.9%  
From Investments Rs m-615-95,098 0.6%  
From Financial Activity Rs m-1,358-321,940 0.4%  
Net Cashflow Rs m403-148,658 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 82.91 Rs / USD

Compare NEULAND LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare NEULAND LABS With: PARNAX LAB  JUBILANT PHARMOVA   HEMO ORGANIC  MANKIND PHARMA  SHREE GANESH REMEDIES   



Today's Market

Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets continued the downtrend as the session progressed and ended the day weak.